Capricor Therapeutics
CAPR
#8048
Rank
ยฃ0.21 B
Marketcap
ยฃ4.70
Share price
-4.36%
Change (1 day)
-59.17%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ0.08 M-99.94%
2025ยฃ0.15 B154.62%
2024ยฃ61.89 M1584.06%
2023ยฃ3.67 M24.67%
2022ยฃ2.94 M-49.93%
2021ยฃ5.88 M-88.57%
2020ยฃ51.49 M573.14%
2019ยฃ7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ24.94 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.02 Mยฃ30.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
ยฃ3.61 Mยฃ34.11 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ6.56 Mยฃ10.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ0.78 Mยฃ0.84 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/Aยฃ1.49 M๐Ÿ‡บ๐Ÿ‡ธ USA